Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
Browse the full article libraryOften yes — doctor-supervised platforms ship cold-chain to hundreds of PIN codes, including many tier-2 and tier-3 towns. Confirm delivery to your pincode before ordering.
Often, yes — most Indian policies exclude weight loss as a lifestyle condition. Claims are more likely to succeed when prescribed for diabetes or another covered condition.
Yes — GLP-1 medicines are prescription-only (Schedule H). Any seller offering them without a prescription is operating illegally and likely selling counterfeits.
Roughly ₹1–3 lakh a year depending on the molecule and dose, often lower in the maintenance phase. Factor in consults and labs, and treat suspiciously cheap offers with caution.
Global weight-loss demand has outstripped supply, and cold-chain logistics limit distribution to smaller cities. When stock is tight, switching to Wegovy or Mounjaro is the usual workaround.
Yes, when it's a licensed pharmacy dispensing against a valid prescription. Telemedicine prescriptions are legal under the 2020 guidelines. Sellers shipping without any prescription are not legitimate.
Use the lowest effective dose, choose the right molecule for your goal, buy a full month at a time, and use medical reimbursement. Never cut costs with counterfeit or shared pens.
Yes, prescription medicines attract 12% GST, which is already built into the MRP. Doctor consultations are GST-exempt; bundled platform fees may attract GST.
Often yes — many Indian CTC packages include a medical-bills reimbursement you can use without pre-approval. Keep the prescription and pharmacy invoice.
It depends on how you buy it. A bundled program like ZIVOLABS folds the consult, prescription and delivery together; buying a pen alone from a pharmacy doesn't include medical supervision.
Likely over time. More manufacturers are entering, and once key patents lapse, generic competition typically brings prices down significantly. Timing is uncertain.
Rybelsus (oral semaglutide) is cheaper, and Trulicity or older liraglutide may cost less than newer options. The cheapest 'alternatives' from unlicensed sellers, though, are a serious safety risk.
